Consolidated Planning Corp acquired a new position in John Wiley & Sons, Inc. (NYSE:WLY - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 14,141 shares of the company's stock, valued at approximately $682,000.
A number of other institutional investors have also modified their holdings of WLY. Louisiana State Employees Retirement System grew its holdings in John Wiley & Sons by 1.4% during the 2nd quarter. Louisiana State Employees Retirement System now owns 21,200 shares of the company's stock worth $863,000 after acquiring an additional 300 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of John Wiley & Sons by 39.2% during the third quarter. GAMMA Investing LLC now owns 1,187 shares of the company's stock valued at $57,000 after buying an additional 334 shares during the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of John Wiley & Sons by 2.0% during the second quarter. The Manufacturers Life Insurance Company now owns 19,308 shares of the company's stock valued at $786,000 after buying an additional 380 shares during the last quarter. Access Investment Management LLC lifted its position in shares of John Wiley & Sons by 0.7% during the second quarter. Access Investment Management LLC now owns 66,755 shares of the company's stock valued at $2,717,000 after buying an additional 480 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System lifted its position in shares of John Wiley & Sons by 5.3% during the first quarter. State Board of Administration of Florida Retirement System now owns 12,826 shares of the company's stock valued at $497,000 after buying an additional 640 shares during the last quarter. 73.94% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at John Wiley & Sons
In related news, EVP Danielle Mcmahan sold 2,318 shares of the stock in a transaction that occurred on Tuesday, October 8th. The shares were sold at an average price of $49.41, for a total value of $114,532.38. Following the completion of the transaction, the executive vice president now directly owns 8,978 shares of the company's stock, valued at $443,602.98. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.62% of the stock is currently owned by insiders.
John Wiley & Sons Trading Up 0.1 %
Shares of WLY stock traded up $0.07 during mid-day trading on Friday, hitting $52.14. 218,800 shares of the stock traded hands, compared to its average volume of 340,372. The stock's fifty day moving average is $48.28 and its two-hundred day moving average is $44.01. John Wiley & Sons, Inc. has a 52-week low of $29.04 and a 52-week high of $52.97. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.53 and a current ratio of 0.57.
John Wiley & Sons (NYSE:WLY - Get Free Report) last released its quarterly earnings results on Thursday, September 5th. The company reported $0.47 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.08). The firm had revenue of $403.81 million for the quarter, compared to analysts' expectations of $387.40 million. John Wiley & Sons had a negative net margin of 6.00% and a positive return on equity of 21.59%. The business's quarterly revenue was down 10.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.27 earnings per share.
John Wiley & Sons Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 24th. Investors of record on Tuesday, October 8th were given a $0.352 dividend. This represents a $1.41 annualized dividend and a dividend yield of 2.70%. The ex-dividend date of this dividend was Tuesday, October 8th. John Wiley & Sons's payout ratio is currently -70.50%.
John Wiley & Sons Company Profile
(
Free Report)
John Wiley & Sons, Inc operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries.
See Also
Before you consider John Wiley & Sons, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and John Wiley & Sons wasn't on the list.
While John Wiley & Sons currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.